{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:04:00Z","timestamp":1787317440694,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010552","name":"Generalitat de Catalunya Departament de Salut","doi-asserted-by":"publisher","award":["2021 SGR 00789"],"award-info":[{"award-number":["2021 SGR 00789"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RED2022-134191-T"],"award-info":[{"award-number":["RED2022-134191-T"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spanish Journal of Psychiatry and Mental Health"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.sjpmh.2025.10.001","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:37:12Z","timestamp":1763649432000},"page":"84-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of prolactin levels and sexual dysfunction in patients on long-acting risperidone ISM vs monthly paliperidone palmitate"],"prefix":"10.1016","volume":"19","author":[{"given":"Javier","family":"Labad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Gabernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Borr\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Niub\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Silles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Toll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Ragull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Hern\u00e1ndez-Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.sjpmh.2025.10.001_bib0075","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1007\/s12325-022-02299-8","article-title":"Risperidone ISM as a new option in the clinical management of schizophrenia: a narrative review","volume":"39","author":"\u00c1lamo","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.sjpmh.2025.10.001_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2021.11.030","article-title":"Long-term efficacy and safety of once-monthly Risperidone ISM\u00ae in the treatment of schizophrenia: results from a 12-month open-label extension study","volume":"239","author":"Filts","year":"2022","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.sjpmh.2025.10.001_bib0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S1461145711001076","article-title":"A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia","volume":"15","author":"Fleischhacker","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.sjpmh.2025.10.001_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139403","article-title":"A non-interventional naturalistic study of the prescription patterns of antipsychotics in patients with schizophrenia from the Spanish Province of Tarragona","volume":"10","author":"Gaviria","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.sjpmh.2025.10.001_bib0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0269881110372817","article-title":"A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia","volume":"25","author":"Gopal","year":"2011","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10.1016\/j.sjpmh.2025.10.001_bib0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00131746-200309000-00003","article-title":"Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects","volume":"9","author":"Halbreich","year":"2003","journal-title":"J Psychiatr Pract"},{"issue":"S416","key":"10.1016\/j.sjpmh.2025.10.001_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","volume":"107","author":"Haro","year":"2003","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"11","key":"10.1016\/j.sjpmh.2025.10.001_bib0110","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamapsychiatry.2023.2696","article-title":"Sexual dysfunction in schizophrenia: a systematic review and meta-analysis","volume":"80","author":"Korchia","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.sjpmh.2025.10.001_bib0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0033-1347177","article-title":"Sexual dysfunction related to psychotropic drugs: a critical review. Part II: antipsychotics","volume":"46","author":"La Torre","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.sjpmh.2025.10.001_bib0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2020.04.031","article-title":"Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: a systematic review and meta-analysis","volume":"222","author":"Labad","year":"2020","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.sjpmh.2025.10.001_bib0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"J Sex Marital Ther"},{"issue":"2","key":"10.1016\/j.sjpmh.2025.10.001_bib0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/17512433.2022.2020641","article-title":"Effects of body weight, smoking status, and sex on plasma concentrations of once-monthly paliperidone palmitate","volume":"15","author":"Schoretsanitis","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.sjpmh.2025.10.001_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpsy.2024.100259","article-title":"Sex differences in changes in prolactin levels and sexual function after switching from risperidone to paliperidone palmitate in schizophrenia","volume":"38","author":"Tost","year":"2024","journal-title":"Eur J Psychiatry"},{"key":"10.1016\/j.sjpmh.2025.10.001_bib0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2021.08.013","article-title":"Prolactin levels influenced by antipsychotic drugs in schizophrenia: a systematic review and network meta-analysis","volume":"237","author":"Zhu","year":"2021","journal-title":"Schizophr Res"}],"container-title":["Spanish Journal of Psychiatry and Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950285325000584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950285325000584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:07:01Z","timestamp":1785884821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950285325000584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2950285325000584"],"URL":"https:\/\/doi.org\/10.1016\/j.sjpmh.2025.10.001","relation":{},"ISSN":["2950-2853"],"issn-type":[{"value":"2950-2853","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of prolactin levels and sexual dysfunction in patients on long-acting risperidone ISM vs monthly paliperidone palmitate","name":"articletitle","label":"Article Title"},{"value":"Spanish Journal of Psychiatry and Mental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjpmh.2025.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Psiquiatr\u00eda y Salud Mental (SEPSM). Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}